English | Español
John Breslin | Nov 17, 2017

Advocates praise Gates' $100 million investment in Alzheimer's research
Carol Ostrow | Nov 17, 2017

Diabetes 360 survey shows patient desire for more holistic care
Carol Ostrow | Nov 16, 2017

STORM Therapeutics names Institute of Cancer Research CEO to board
Carol Ostrow | Nov 16, 2017

European study demonstrates economic benefits of Tresiba
Marian Johns | Nov 16, 2017

Patient groups say Orphan Drug Tax Credit repeal could result in fewer treatments for rare diseases
Marian Johns | Nov 16, 2017

Scientists call for more clinical studies of nonchemotherapy drugs

Kathy Adams | Nov 16, 2017

Philadelphia Insurance Companies sponsors American Diabetes Association camp program
Kathy Adams | Nov 15, 2017

AbbVie executive to present at Jefferies London Healthcare Conference

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’